110478 ⎘
ssDNA viruses; Details; Circoviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
IDENTIFICATION OF A HUMAN CIRCOVIRUS
#2Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#3METHODS OF MANUFACTURING PORCINE ENDOGENOUS RETROVIRUS (PERV) FREE ANIMAL HEALTH VACCINES
#4PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF
#5MULTIVALENT VACCINE COMPOSITION FOR PREVENTION OF PORCINE MYCOPLASMA AND PORCINE CIRCOVIRUS INFECTIONS
#6Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#7PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#8PCV2 ORF2 protein variant and virus like particles composed thereof
#9A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG
#10Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
#11IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#12Vaccine delivery method
#13PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE
#14Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#15Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same
#16PLANT PRODUCED PORCINE CIRCOVIRUS PSEUDOVIRION
#17PCV2 ORF2 protein variant and virus like particles composed thereof
#18Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#19Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
#20Vaccine treatment and control infectious against viral pathogens utilizing heparan sulfate (HS) as cellular receptor
#21Immunogenic compositions comprising
#22Vaccine delivery method
#23RECOMBINANT SWINEPOX VIRUS AND VACCINES
#24PCV/mycoplasma hyopneumoniae vaccine
#25Mycoplasma hyopneumoniae vaccine
#26IMMUNOGENIC COMPOSITION AND METHOD OF ENHANCING IMMUNE RESPONSE IN HOSTS
#27Recombinant expression of PCV2b ORF2 protein in insect cells
#28Combination vaccine for swine
#29Antigen fused with porcine Fc fragment and vaccine composition comprising the same
#30Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#31Porcine circovirus type 3 strain, vaccine composition, method of making the same and use thereof
#32Multivalent recombinant SPV
#33PCV/vaccine for use with PRRSV vaccine
#34Marker system, in particular for baculovirus-expressed subunit antigens
#35vaccine
#36Immunogenic compositions comprising
#37Vaccine for intradermal application against PCV2 and PRRS virus infection
#38Combination vaccine against PCV2 and PRRS virus infection comprising albumin
#39Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
#40PCV2 ORF2 protein variant and virus like particles composed thereof
#41PCV2 ORF2 carrier platform
#42Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#43Treatment of pigs with PCV2 antigen
#44Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#45Method for porcine circovirus production and PCV2 vaccines
#46PCV2 immunogenic compositions and methods of producing such compositions
#47Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#48Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#49Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies
#50Circovirus sequences associated with piglet weight loss disease (PWD)
#51Process for ready-to-use PCV/M.Hyo combination vaccine
#52Recombinant swinepox virus and vaccines
#53Multi-dose compositions containing an antimicrobial polyamide or octenidine preservative
#54PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE
#55Vaccine for PCV2 and mycoplasma
#56PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine
#57Mycoplasma hyopneumoniae vaccine
#58VACCINE DELIVERY METHOD
#59VACCINES WITH INTERLEUKIN-17 AS AN ADJUVANT
#60Live attenuated chimeric porcine circovirus vaccine
#61Vaccine against porcine circo virus type 2
#62Prevention and treatment of sub-clinical PCVD
#63Treatment of PRDC in pigs
#64Treatment of pigs with PCV2 antigen
#65Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#66PCV2 ORF2 protein variant and virus like particles composed thereof
#67Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#68Method for the preparation of a vaccinating agent
#69Production of polypeptides relevant to human and animal health using
#70Immunogenic compositions comprising
#71Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
#72Method for porcine circovirus production and PCV2 vaccines
#73Vaccine against Lawsonia intracellularis and porcine circovirus 2
#74Marker system, in particular for baculovirus-expressed subunit antigens
#75Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#76PCV2B divergent vaccine composition and methods of use
#77ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION
#78Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#79Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#80Production of polypeptides relevant to human and animal health using
#81Vaccine for PCV2 and mycoplasma
#82Recombinant baculovirus vector and uses thereof
#83Fusion polypeptides and vaccines
#84RECOMBINANT ANTIGENS OF THE PORCINE CIRCOVIRUS 2 (PCV-2) FOR VACCINE FORMULATIONS AND USE THEREOF
#85Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof
#86Prevention and treatment of sub-clinical PCVD
#87Effective method of treatment of porcine circovirus and infections
#88Baculovirus system for expressing proteins forming virus-like particles
#89Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#90Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#91Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#92PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#93vaccine
#94PCV/combination vaccine
#95Prophylaxis and treatment of PRDC
#96PCV2 ORF2 VIRUS LIKE PARTICLE WITH FOREIGN AMINO ACID INSERTION
#97Vaccine formulations comprising saponin-containing adjuvants
#98Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#99PCV2 immunogenic compositions and methods of producing such compositions
#100Circovirus sequences associated with piglet weight loss disease (PWD)
#101Circovirus sequences associated with piglet weight loss disease (PWD)
#102PCV2 immunogenic compositions and methods of producing such compositions
#103PCV2 ORF2 protein variant and virus like particles composed thereof
#104PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE
#105Treatment of pigs with PCV2 antigen
#106Synthetic capsid proteins and uses thereof
#107METHOD FOR THE REDUCTION OF PCV-2 IN A HERD OF SWINE
#108Porcine circovirus type-2 (PCV2) subunit vaccine
#109Immunogenic compositions comprising
#110Live attenuated chimeric porcine circovirus vaccine
#111Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#112Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#113Expression cassette for efficient surface display of antigenic proteins
#114Reduction of concomitant infections in pigs by the use of PCV2 antigen
#115Prevention and treatment of sub-clinical PCVD
#116PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#117PCV/combination vaccine
#118vaccine
#119Vaccine for protection against and Porcine circo virus
#120Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#121PCV2 immunogenic compositions and methods of producing such compositions
#122Infectious clones of torque teno virus
#123Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#124Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#125Circovirus sequences associated with piglet weight loss disease (PWD)
#126Circovirus sequences associated with piglet weight loss disease (PWD)
#127METHODS AND COMPOSITIONS FOR IMMUNIZING PIGS AGAINST PORCINE CIRCOVIRUS
#128Live attenuated chimeric porcine circovirus vaccine
#129PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#130Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#131PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF
#132Prevention and treatment of sub-clinical PCVD
#133MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE
#134Circovirus sequences associated with piglet weight loss disease (PWD)
#135TREATMENT OF PRDC IN PIGS
#136Vaccine formulations comprising saponin-containing adjuvants
#137Treatment of pigs with PCV2 antigent
#138PCV-2 vaccine
#139Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity
#140Methods of reducing concomitant infections in pigs with a PCV2 antigen
#141Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#142VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS
#143METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
#144Circovirus sequences associated with piglet weight loss disease (PWD)
#145PCV2 ORF2 VIRUS LIKE PARTICLE WITH FOREIGN AMINO ACID INSERTION
#146Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#147CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#148Circovirus sequences associated with piglet weight loss disease (PWD)
#149CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#150CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#151CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#152CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#153CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#154Circovirus sequences associated with piglet weight loss disease (PWD)
#155CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#156CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#157CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#158CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#159METHODS AND COMPOSITIONS IN THE TREATMENT OF PORCINE CIRCOVIRAL INFECTION
#160CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#161CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#162Culturing circular ssDNA viruses for the production of vaccines
#163PCV 2-Based Methods and Compositions for the Treatment of Pigs
#164METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS
#165EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
#166Circovirus sequences associated with piglet weight loss disease (PWD)
#167NEW VACCINE FORMULATIONS
#168Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#169Culturing circular ssDNA viruses for the production of vaccines
#170PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#171Porcine circovirus type 2 vaccines
#172Circovirus sequences associated with piglet weight loss disease (PWD)
#173Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
#174Circovirus sequences associated with piglet weight loss disease (PWD)
#175Reduction of concomitant infections in pigs by the use of PCV2 antigen
#176Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#177Circovirus sequences associated with piglet weight loss disease (PWD)
#178Methods of overexpression and recovery of porcine circovirus type 2 ORF2
#179PCV2 immunogenic compositions and methods of producing such compositions
#180PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#181PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#182PCV2 immunogenic compositions and methods of producing such compositions
#183Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
#184PCV2 immunogenic compositions and methods of producing such compositions
#185Prevention and treatment of sub-clinical PCVD
#186Treatment of PRDC in pigs
#187Raccoon Poxvirus Expressing Genes of Porcine Virus
#188USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#189Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#190Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#191USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#192Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#193Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#194PCV-2 vaccine
#195Circovirus sequences associated with piglet weight loss disease (PWD)
#196MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#197Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#198Vaccine formulations
#199USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#200Chicken Anemia Virus Vaccine from Cell Line
#201Circovirus sequences associated with piglet weight loss disease (PWD)
#202Culturing circular ssDNA viruses for the production of vaccines
#203Culturing circular ssDNA viruses for the production of vaccines
#204Circovirus sequences associated with piglet weight loss disease (PWD)
#205Circovirus sequences associated with piglet weight loss disease (PWD)
#206Circovirus sequences associated with piglet weight loss disease (PWD)
#207Circovirus sequences associated with piglet weight loss disease (PWD)
#208Circovirus sequences associated with piglet weight loss disease (PWD)
#209Circovirus sequences associated with piglet weight loss disease (PWD)
#210Circovirus sequences associated with piglet weight loss disease (PWD)
#211Circovirus sequences associated with piglet weight loss disease (PWD)
#212Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#213Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
#214Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
#215Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
#216Circovirus sequences associated with piglet weight loss disease (PWD)
#217Circovirus sequences associated with piglet weight loss disease (PWD)
#218Immunogenic compositions comprising
#219Circovirus sequences associated with piglet weight loss disease (PWD)
#220Porcine circovirus and Helicobacter combination vaccines and methods of use
#221Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
#222Circovirus sequences associated with piglet weight loss disease (PWD)
#223Chicken anemia virus vaccine from cell line
#224Coronavirus-like particles comprising functionally deleted genomes
#225Circovirus sequences associated with piglet weight loss disease (PWD)
#226Vaccine formulations
#227Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
#228Circovirus sequences associated with piglet weight loss disease (PWD)